Comparative study on clinical therapeutic effect of insulin aspart and biosynthetic human insulin in the treatment of newly diagnosed type 2 diabetes
-
摘要: 目的 比较门冬胰岛素与生物合成人胰岛素治疗新诊断Ⅱ型糖尿病的临床疗效.方法 将新诊断的96例Ⅱ型糖尿病患者随机均分为2组,分别为门冬胰岛素(治疗)组和生物合成人胰岛素(对照)组.患者分别在每日餐前给予皮下注射门冬胰岛素和生物合成人胰岛素,且均每晚定时皮下注射一次甘精胰岛素.比较2组患者血糖、低血糖事件、胰岛素用量的差异.结果 用药后2组餐前及餐后的血糖含量均明显降低,且门冬胰岛素组餐前、餐后血糖均低于生物合成人胰岛素组；门冬胰岛素组患者低血糖发生次数低于生物合成人胰岛素组,差异有统计学意义；但2组胰岛素用量无显著差异.结论 门冬胰岛素能够更好地控制Ⅱ型糖尿病的血糖,对Ⅱ型糖尿病的治疗更加有效.
-
-
职心乐, 王建华. 天津Ⅱ型糖尿病患病情况调查及相关危险因素研究 [J]. 中国糖尿病杂志, 2009(4):275. Esteghamati A, Rajabian R, Amini M. The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes:an open-label, non-randomised, multicentre observational study-the Iran subgroup of the IMPROVE study [J]. Endokrynologia Polska, 2010(4):364. Trippe B S, Shepherd M D, Coulter FC. Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial) [J]. Current Medical Research and Opinion, 2012(7):1203. 赵润年, 杨世民, 刘莲叶. 门冬胰岛素强化治疗新诊断Ⅱ型糖尿病的临床观察 [J]. 临床研究, 2011(8):563. 乔旭霞. 门冬胰岛素与生物合成人胰岛素分别联合甘精胰岛素治疗Ⅱ型糖尿病的临床比较 [J]. 当代医学, 2010(2):5. Dashora U, Ashwell S G, Home P D. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes [J]. Diabetes, Obesity and Metabolism, 2009(7):680. Ashwell S G, Gebbie J, Home P D. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart [J]. Diabetic Medicine, 2006(8):879. Mathiesen E R, Kinsley B, Amiel S A. Insulin Aspart Pregnancy Study Group.Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy:a randomized trial of insulin aspart versus human insulin in 322 pregnant women [J]. Diabetes Care, 2007(4):771.
计量
- 文章访问数: 156
- HTML全文浏览量: 23
- PDF下载量: 1
下载:
苏公网安备 32100302010246号